AE

Allen Ebens

Prescient Therapeutics Limited | Non-Executive Director
Dr Ebens is Chief Science Officer at Vera Therapeutics, a San Francisco California based biotechnology company. Dr Ebens is a drug developer, having overseen the advancement of multiple drug development projects from concept to clinical development including polatuzumab, which is approved by the US FDA and is now marketed for use in diffuse large B-cell lymphoma.

Company and Role

Company
Title
Tenure
Since
PTX
Prescient Therapeutics Limited
  • Non-Executive Director
3yrs, 11mthJun 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PTX
Prescient Therapeutics Limited
30/06/23N/AN/A1,415,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PTX
Prescient Therapeutics Limited
10/12/20
Issued
1,000,000$0.064$64,000Issue of options